At the beginning of the action, a couple of publications claimed the effectivity of this technology in biological tissues decellularization. From the starting date of CriTiClean (2017), new research groups around the world (eight so far) have shown their achievements in the field. CriTiClean increased the knowledge of this novel biomedical application of pressurized CO2-based fluids.
In particular, this action contributed to:
- the lipid composition of several biological tissues from pigs, i.e. pulmonary arteries, retina and cava veins.
- the selectivity and efficiency of lipid removal by pressurized CO2-mixtures, especially when ethanol-water or limonene were added.
- the poor efficiency of neat supercritical CO2 to remove lipids. Only triacylglycerides content was decreased.
- the correlation between delipidation and the fluid composition.
- the high delipidation efficiency of pressurized CO2-ethanol-water .
- the positive dsDNA removal effect of pressurized CO2-limonene mixtures by a tentative enhancement of the further enzymatic activity (dsDNAses).
- the unsuccessful results related to dsDNA removal from electroporation or pressurized hot water extraction (with/without benzoases) before and after pressurized CO2-mixtures approaches.
- the new suitable alternative based on sequential CO2-based mixtures extractions for both lipids and dsDNA removal in one step (data are currently being analyzed).
- the preservation of ECM integrity after pressurized CO2-based extractions.
CriTiClean dissemination allowed us to set new collaborations, which shows the increasing interest of the scientific community. On May 2019, Dr. Gil-Ramírez was interviewed by Mrs. Aisling Irwin, a science journalist of ´Horizon, the EU Research and Innovation magazine´, which resulted in the publication ´Transplant recipients may soon have a test to protect against organ rejection´(
https://horizon-magazine.eu/article/transplant-recipients-may-soon-have-test-protect-against-organ-rejection.html(s’ouvre dans une nouvelle fenêtre)). CriTiClean is expected to be a prequel of new projects.